These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26679106)

  • 1. Chemopreventive agents targeting tumor microenvironment.
    Sharma SH; Thulasingam S; Nagarajan S
    Life Sci; 2016 Jan; 145():74-84. PubMed ID: 26679106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming of the tumour microenvironment.
    Xing Y; Zhao S; Zhou BP; Mi J
    FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tumor cells and tumor microenvironment on NK-cell function.
    Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
    Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
    Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
    Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of mast cells in anticancer immunity.
    Dalton DK; Noelle RJ
    Cancer Immunol Immunother; 2012 Sep; 61(9):1511-20. PubMed ID: 22527244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment.
    Casazza A; Di Conza G; Wenes M; Finisguerra V; Deschoemaeker S; Mazzone M
    Oncogene; 2014 Apr; 33(14):1743-54. PubMed ID: 23604130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune cells in the tumor microenvironment.
    Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N
    Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
    Albini A; Bruno A; Noonan DM; Mortara L
    Front Immunol; 2018; 9():527. PubMed ID: 29675018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of the tumor microenvironment in the therapeutic management of cancer.
    Pottier C; Wheatherspoon A; Roncarati P; Longuespée R; Herfs M; Duray A; Delvenne P; Quatresooz P
    Expert Rev Anticancer Ther; 2015; 15(8):943-54. PubMed ID: 26098949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overlooked tumor promoting immunoregulation by non-hematopoietic stromal cells.
    Bose A; Ghosh T; Baral R
    Immunol Lett; 2016 Aug; 176():114-21. PubMed ID: 27311851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.
    Ferrari SM; Fallahi P; Galdiero MR; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Varricchi G; Marone G; Antonelli A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune network in pancreatic cancer development and progression.
    Wörmann SM; Diakopoulos KN; Lesina M; Algül H
    Oncogene; 2014 Jun; 33(23):2956-67. PubMed ID: 23851493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the microenvironment in solid tumors.
    Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
    Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of herbal medicines as tumor microenvironment-modulating agents.
    Park CR; Lee JS; Son CG; Lee NH
    Phytother Res; 2021 Jan; 35(1):78-94. PubMed ID: 32658314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.